blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1274404

EP1274404 - METHOD AND COMPOSITION FOR TREATING CANCER BY ADMINISTRATION OF APOPTOSIS-INDUCING CHEMOTHERAPEUTIC AGENTS [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  14.01.2005
Database last updated on 02.11.2024
Most recent event   Tooltip14.01.2005Withdrawal of applicationpublished on 02.03.2005  [2005/09]
Applicant(s)For all designated states
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
5 Basel Street, P.O. Box 3190
49131 Petah Tiqva / IL
[N/P]
Former [2003/03]For all designated states
TEVA PHARMACEUTICAL INDUSTRIES LTD.
5 Basel Street, P.O. Box 3190
49131 Petah Tiqva / IL
Inventor(s)01 / FLASHNER-BARAK, Moshe
Hefetz Mordechai 15
Petach Tikva / IL
 [2003/03]
Representative(s)Gallagher, Kirk James, et al
D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
[N/P]
Former [2003/03]Gallagher, Kirk James, et al
D Young & Co, 21 New Fetter Lane
London EC4A 1DA / GB
Application number, filing date01926824.210.04.2001
[2003/03]
WO2001US11688
Priority number, dateUS20000195920P10.04.2000         Original published format: US 195920 P
[2003/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0176567
Date:18.10.2001
Language:EN
[2001/42]
Type: A1 Application with search report 
No.:EP1274404
Date:15.01.2003
Language:EN
The application published by WIPO in one of the EPO official languages on 18.10.2001 takes the place of the publication of the European patent application.
[2003/03]
Search report(s)International search report - published on:US18.10.2001
ClassificationIPC:A61K9/52, A61K9/66
[2003/03]
CPC:
A61K9/0019 (EP,US); A61K9/50 (KR); A61K31/337 (EP,US);
A61K38/38 (EP,US); A61K38/39 (EP,US); A61K45/06 (EP,US);
A61K47/42 (EP,US); A61K9/1647 (EP,US); A61P35/00 (EP);
A61P35/04 (EP); A61P43/00 (EP) (-)
C-Set:
A61K31/337, A61K2300/00 (EP,US);
A61K38/38, A61K2300/00 (US,EP);
A61K38/39, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/03]
Extension statesALNot yet paid
LT08.11.2002
LV08.11.2002
MKNot yet paid
RO08.11.2002
SI08.11.2002
TitleGerman:METHODE UND ZUSAMMENSETZUNG ZUR KREBSBEHANDLUNG DURCH VERABREICHUNG APOPTOSIS INDUZIERENDER CHEMOTHERAPEUTISCHER WIRKSTOFFE[2003/03]
English:METHOD AND COMPOSITION FOR TREATING CANCER BY ADMINISTRATION OF APOPTOSIS-INDUCING CHEMOTHERAPEUTIC AGENTS[2003/03]
French:METHODE ET COMPOSITION SERVANT A TRAITER LE CANCER PAR ADMINISTRATION D'AGENTS CHIMIOTHERAPEUTIQUES INDUISANT L'APOPTOSE[2003/03]
Entry into regional phase08.11.2002National basic fee paid 
08.11.2002Search fee paid 
08.11.2002Designation fee(s) paid 
08.11.2002Examination fee paid 
Examination procedure30.10.2001Request for preliminary examination filed
International Preliminary Examining Authority: US
08.11.2002Amendment by applicant (claims and/or description)
08.11.2002Examination requested  [2003/03]
05.01.2005Application withdrawn by applicant  [2005/09]
Fees paidRenewal fee
14.04.2003Renewal fee patent year 03
31.03.2004Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US4345588  (WIDDER KENNETH J, et al);
 [X]US4492720  (MOSIER BENJAMIN [US]);
 [Y]WO9913914  (HUMAN RT [HU], et al);
 [X]  - DHANIKULA ET AL., "Localized paclitaxel delivery", INTERNATIONAL JOURNAL OF PHARMACEUTICS, (1999), vol. 183, pages 85 - 100, XP002941842

DOI:   http://dx.doi.org/10.1016/S0378-5173(99)00087-3
 [X]  - KUMAGAI ET AL., "Improvement of intraperitoneal chemotherapy for rat overian cancer using cisplatin-containing microspheres", JAPANESE JOURNAL OF CANCER RESEARCH, (199604), vol. 87, pages 412 - 417, XP002941843
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.